5 citations
,
January 2016 in “BLDE University Journal of Health Sciences” This study observed that Kasisa Bhasma is safer and less toxic than Shodhita Kasisa, particularly at higher doses, when administered to experimental rats.
This study suggests that bioactives like Curcumin, Quercetin, and "Tulsi" may relieve chemotherapy-induced adverse drug reactions in cancer patients, potentially reducing resistance and recurrence.
September 2015 in “International Journal of Ayurvedic Medicine” This study introduces a new Drug Efficacy Index to predict the effectiveness of various Ayurvedic hair care formulations and modern medicines.
September 2026 in “Adolescencia e Saude” This study found that an integrative Ayurvedic adjunctive program helped mitigate adverse drug reactions from anti-tubercular treatment, leading to improved weight, respiratory function, and reduced gastrointestinal toxicity in a patient with pulmonary tuberculosis.
October 2023 in “Journal of Indian System of Medicine” This study discusses how Ayurveda approaches the management of premature hair greying differently than contemporary science, emphasizing lifestyle regimens, rejuvenation practices, and the use of herbal drugs rooted in Ayurveda pharmacodynamics.